Publication | Closed Access

Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial

InflammationRheumatologyRheumatoid DisorderAnti-inflammatoryOption StudyAutoimmune DiseaseRheumatic DiseasesRandomised TrialImmunologyAutoimmunityInflammatory Rheumatic DiseaseMedicineRheumatoid Arthritis